Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment.
暂无分享,去创建一个
[1] P. E. Simonsen,et al. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[2] G. Weil,et al. A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. , 1999, The American journal of tropical medicine and hygiene.
[3] P. E. Simonsen,et al. Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[4] P. E. Simonsen,et al. Bancroftian filariasis in an irrigation project community in southern Ghana , 1999, Tropical medicine & international health : TM & IH.
[5] M. Alpers,et al. Absence of ivermectin-associated excess deaths. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[6] D. Meyrowitsch,et al. Long-term effect of mass diethylcarbamazine chemotherapy on bancroftian filariasis, results at four years after start of treatment. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] G. Weil,et al. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[8] E. Michael,et al. Global mapping of lymphatic filariasis. , 1997, Parasitology today.
[9] D. Molyneux,et al. Onchocerciasis control: Moving towards the millennium. , 1997, Parasitology today.
[10] A. Hightower,et al. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. , 1997, The American journal of tropical medicine and hygiene.
[11] A. Hightower,et al. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children , 1997, The Lancet.
[12] R. Reintjes,et al. Deaths associated with ivermectin for scabies , 1997, The Lancet.
[13] D. Bundy,et al. Anthelmintics. A comparative review of their clinical pharmacology. , 1997, Drugs.
[14] R. Barkwell,et al. Deaths associated with ivermectin treatment of scabies , 1997, The Lancet.
[15] J. Habbema,et al. Ivermectin for the chemotherapy of bancroftian filariasis: a meta‐analysis of the effect of single treatment , 1997, Tropical medicine & international health : TM & IH.
[16] L. Nicolas,et al. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. , 1997, The Journal of infectious diseases.
[17] D. Meyrowitsch,et al. Wuchereria bancrofti in Tanzania: microfilarial periodicity and effect of blood sampling time on microfilarial intensities , 1997, Tropical medicine & international health : TM & IH.
[18] C. R. Horsburgh,et al. Pathology of emerging infections , 1997 .
[19] B. Duke,et al. Strategies and tools for the control/elimination of lymphatic filariasis. , 1997, Bulletin of the World Health Organization.
[20] P. E. Simonsen,et al. Lymphatic filariasis on the coast of Ghana. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[21] G. Weil,et al. Parasite antigenemia without microfilaremia in bancroftian filariasis. , 1996, The American journal of tropical medicine and hygiene.
[22] D. Addiss,et al. Ultrasonographic assessment of the adulticidal efficacy of repeat high‐dose ivermectin in bancroftian filariasis , 1996, Tropical medicine & international health : TM & IH.
[23] A. Georges,et al. Current knowledge on the epidemiology, diagnosis, immunology, and treatment of loiasis. , 1995, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[24] D. Freedman,et al. Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. , 1995, The American journal of tropical medicine and hygiene.
[25] H. Gilles,et al. Diethylcarbamazine in the treatment of patients with onchocerciasis. , 1992, British journal of clinical pharmacology.
[26] G. Weil,et al. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin. , 1991, The Journal of infectious diseases.
[27] K. Goa,et al. Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. , 1991, Drugs.
[28] S. More,et al. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. , 1990, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.